Saturday, October 3, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleSeeking Alpha· February 19, 2026

Oceaneering projects $390M–$440M EBITDA for 2026 as ADTech drives multiyear growth

View original at seekingalpha.com
Oceaneering projects $390M–$440M EBITDA for 2026 as ADTech drives multiyear growth Earnings Call Insights: Oceaneering International, Inc…
Opening lines of the source · Seeking Alpha · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Achieved 7% improvement in ROV pricing

    80% confidence
  • Interest in autonomous forklifts is high with adoption depending on customer readiness

    80% confidence
  • Not pursuing big industry consolidation M&A but sees potential for bolt-on technology acquisitions

    80% confidence
  • Oceaneering closed out 2025 with strong execution across the business, making continued progress against strategic priorities

    80% confidence
  • Government services lead times for ADTech projects vary quite a bit, with some ramping quickly and others requiring longer engineering and prototyping phases

    80% confidence
  • Organic capital expenditures for 2026 forecasted between $105 million and $115 million, with 40% allocated to growth and 60% to maintenance

    80% confidence
  • Cash balance increased to $689 million at year-end, further strengthening financial flexibility

    80% confidence
  • Achieved 140 basis points EBITDA margin expansion in 2025

    80% confidence
  • Net income of $178 million or $1.76 per share represents a 217% increase year-over-year, largely due to $156 million discrete tax benefit related to release of U.S. valuation allowances

    80% confidence
  • ROV uptime was 99% for the second consecutive year

    80% confidence
  • 2025 order intake was $3.7 billion with a book-to-bill ratio of 1.33

    80% confidence
  • Oceaneering's offshore, maritime, and space expertise translates across defense and energy with unique SUBSAFE certifications and capabilities in submarine sustainment and space systems

    80% confidence
  • Free cash flow for 2026 anticipated to be $100 million to $120 million, with year-over-year reduction primarily reflecting early receipt of $37 million in customer payments in Q4 2025

    80% confidence
  • IMDS integrates machine vision, machine learning, and AI for enhanced inspection capabilities that can be deployed subsea with ROVs

    80% confidence
  • 2026 EBITDA projected between $390 million and $440 million with year-over-year improvements in all segments except OPG

    80% confidence
  • Consolidated revenue in 2026 projected to grow in the low to mid-single-digit percentage range, with ADTech revenue improving significantly year-over-year

    80% confidence
  • Balance sheet strength and cash growth gives more flexibility and opportunity to do more when the time is right

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com